I’ve dabbled from time to time with busted biotech companies trading for less than cash value; however, it’s not an especially easy way to make money, IMO.
In general, I’d rather buy biotech companies with legitimate prospects whose enterprise values are cheap (but not necessarily negative).
Market Data 
Markets 
AI
